封面
市場調查報告書
商品編碼
2008049

動物疫苗市場:依產品類型、應用、通路和地區分類。

Animal Vaccines Market, By Product Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,動物疫苗市場規模將達到98.157億美元,2033年將達到152.756億美元。預計從2026年到2033年,其複合年成長率將達到6.6%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 98.157億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.60% 2033年市場規模預測: 152.756億美元

動物疫苗是用於預防和治療各種獸醫疾病的注射劑型。它們在經濟有效地維護寵物和牲畜的健康、壽命和整體生產力方面發揮著至關重要的作用。伴侶動物疫苗有助於預防各種疾病從動物傳播給人類。這些疫苗是注射劑型,用於預防和治療多種疾病,包括芽生菌病、鸚鵡熱和貓抓病。

市場動態

疫苗是用於預防多種疾病的藥物。有些疫苗價格昂貴且難以取得。因此,全球動物疫苗市場的許多公司都提供報銷方案,以減輕寵物疫苗接種的費用,預計這將推動預測期內的市場成長。例如,使用 ULTRA Duramune DAP 組合疫苗和 Bronchi-Shield ORAL 口服疫苗治療的犬隻,Elanco 將報銷因犬副流感病毒感染而導致呼吸道疾病的診斷和治療的常規費用(最高 5,000 美元)。此外,Elanco 還將報銷用於確診的標準且合理的診斷測試(切片檢查和組織病理學檢查)的費用。如果確診,Elanco 將報銷最高 1,500 美元的標準且合理的治療費用。對於接受「ULTRA Duramune DAP」聯合疫苗和「Bronchi-Shield ORAL」治療的犬隻,Elanco 將報銷與犬副流感病毒感染引起的呼吸道疾病的診斷和治療相關的通常和慣常費用(最高 5,000 美元)。

此外,多家寵物健康保險公司提供疫苗接種、身體檢查、洗牙、絕育以及其他寵物健康相關活動的保險。這些寵物健康保險公司包括美國預防虐待動物協會寵物保險 (ASPCA Pet Insurance)、PetFirst 保險、Embrace 寵物保險代理公司、PetPlan 和 Allstate 保險公司。

本次調查的主要特點。

  • 本報告對預測期(2021-2028 年)內全球動物疫苗市場的規模進行了詳細分析,以 2020 年為基準年。
  • 本報告指出了各個細分市場的潛在商機,並說明了該市場中一系列有吸引力的投資提案。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本報告根據以下參數對全球動物疫苗市場的主要企業進行了分析:公司概況、產品系列、主要亮點、財務績效和策略。
  • 透過利用本報告中提出的見解,企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 本報告面向該產業的各類相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球動物疫苗市場時所使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 促進因素和阻礙因素
  • 機會
  • 影響分析
  • 主要進展
  • 新產品發布
  • 合作關係與協議
  • 科技趨勢
  • 品牌分析
  • 法規環境
  • 流行病學
  • 兌換系統
  • 波特五力分析

第4章 全球動物疫苗市場:依產品類型分類,2026-2033年

  • 減毒活病毒疫苗
  • 結合疫苗
  • 去活化疫苗
  • 次單位疫苗
  • 類毒素疫苗
  • DNA疫苗
  • 基因改造疫苗

第5章 全球動物疫苗市場:依應用領域分類,2026-2033年

  • 伴侶動物
  • 家畜
  • 家禽
  • 水產養殖

第6章:全球動物疫苗市場:依通路分類,2026-2033年

  • 獸醫診所
  • 動物醫院
  • 獸醫研究所
  • 其他

第7章 全球動物疫苗市場:依地區分類,2026-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 公司簡介
    • Merck &Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Ceva
    • HIPRA
    • Romvac Company Sa
    • Biovac
    • Vaxxinova International BV
    • Biogenesis Bago

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI4989

Animal Vaccines Market is estimated to be valued at USD 9,815.7 Mn in 2026 and is expected to reach USD 15,275.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 9,815.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.60% 2033 Value Projection: USD 15,275.6 Mn

Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others.

Market Dynamics

Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection.

Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others.

Key features of the study

  • This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global animal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogenesis Bago
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market

Market Segmentation

  • By Product Type
    • Attenuated Live Vaccines
    • Conjugate Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • By Application
    • Companion Animal
    • Livestock Animal
    • Poultry
    • Aquaculture
  • By Distribution Channel
    • Veterinary Clinics
    • Veterinary Hospitals
    • Veterinary Research Institutes
    • Others
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH.
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Ceva
    • HIPRA
    • Romvac Company Sa
    • Biovac
    • Vaxxinova International BV
    • Biogenesis Bago

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers and Restraints
  • Opportunities
  • Impact Analysis
  • Key developments
  • New Product Launches
  • Partnerships and Agreements
  • Technological Landscape
  • Brand Analysis
  • Regulatory Scenario
  • Epidemiology
  • Reimbursement Schemes
  • PORTER Analysis

4. Global Animal Vaccines Market, By Product Type, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2032 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Attenuated Live Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Conjugate Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Inactivated Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Subunit Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Toxoid Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • DNA Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Recombinant Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Animal Vaccines Market, By Application, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2032 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Companion Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Livestock Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Poultry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Aquaculture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Animal Vaccines Market, By Distribution Channel, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2032 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Veterinary Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Veterinary Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Veterinary Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Animal Vaccines Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Zoetis Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Elanco Animal Health Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ceva
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • HIPRA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Romvac Company Sa
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Strategies
    • Biovac
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Strategies
    • Vaxxinova International BV
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Strategies
    • Biogenesis Bago
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Strategies

9. Section

  • Research Methodology
  • About Us